UNSPSC 51284612: Meropenem anhydrous

This classification denotes a beta-lactam antibiotic with the molecular formula C17H25N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YOP6PX0BAO, chemically known as (4r,5s,6s)-3-(((3s,5s)-5-(dimethylcarbamoyl)-3-pyrrolidinyl)thio)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, but more generally known as meropenem anhydrous, which bears US NIH Compound Identifier 64778.

UNSPSC 51284612 Meropenem anhydrous is a Commodity code nominally tied to a specific antibiotic product, but recent state and local procurement activity under this code does not involve meropenem procurement. The code shows no alignment between its nominal scope and actual buying activity: the opportunities posted against it cover naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals through cooperative purchasing. These solicitations address pharmaceutical access and emergency medical supply chains, not meropenem in particular. The issuing bodies span state health and human services commissions, county health systems, municipal fire departments, and multistate cooperative purchasing alliances, suggesting the code may be used as a catch-all for pharmaceutical procurement across diverse jurisdiction types.

Recent activity appears concentrated in Florida, Texas, and Minnesota. Seminole County, Florida posted an IFB (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to its Community Health Building, potentially FEMA-funded. The Texas Health and Human Services Commission issued an RFI (due April 3, 2026) exploring direct-to-manufacturer prescription contracting models with self-insured employers and state agencies. The City of Tampa's Purchasing Department solicited medical and first aid supplies (due March 13, 2026) for the Tampa Fire Department Rescue Division under a Small Local Business Enterprise set-aside, with an estimated contract value of $700,000 and a 5% bid discount cap of $10,000 for certified SLBEs. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with awards effective July 1, 2026, and a two-year initial term. The code shows little relevant activity for meropenem-specific procurement and may not be the appropriate classification for focused market analysis in this product family.